Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Sona Nanotech Inc > FDA COVID test submission approval rate
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(56)
•••
Comment by danjones20000on Sep 21, 2020 10:37am
276 Views
Post# 31590880

RE:RE:RE:RE:FDA COVID test submission approval rate

RE:RE:RE:RE:FDA COVID test submission approval rate
Bd Veritor System For Rapid Detection Of Sars-Cov-2 Becton Dickinson And Company (Bd)

Antigen Technology

Lab-based test and Point of care test

 Under review
Biocredit Covid-19 Ag Rapigen Inc. (South Korea) Antigen Technology Point of care test Under Review
Panbio Covid-19 Ag Rapid Test Device (Nasopharyngeal) Abbott Rapid Diagnostics (Germany) Antigen Technology Lab-based test and point of care test Awaiting response from manufacturer
Sofia 2 Sars Antigen Fia Diagnostic Hybrids, Inc. - also trading as Quidel Corporation (United States) Antigen Technology Lab-based test / Point of care test Under review
Sona Nanotech Covid-19 Lateral Flow Assay Sona Nanotech Inc. (Canada) Antigen Technology Point of care test Under Review
Standard Q COVID-19 AG Test SD Biosensor, Inc. (Korea) Antigen Technology Point of care test Under Review

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities